SUTRO BIOPHARMA, INC. — Director's Dealing 2024

Mar 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SUTRO BIOPHARMA, INC. (STRO)
CIK: 0001382101
Period of Report: 2024-03-01

Reporting Person: ALBINI EDWARD C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-01	Common Stock	M	7875	—	Acquired	98667	Direct
2024-03-01	Common Stock	F	3227	$4.95	Disposed	95440	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-01	Restricted Stock Unit (RSU)	$	M	7875	Disposed	2027-03-01	Common Stock (7875)	Direct

Footnotes

F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.

F2: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.

F3: The RSU award vests as to 1/4th of the total award annually beginning on March 1, 2024, subject to continued service through each vesting date.